Cancer Health Treatment Update Beyond Chemotherapy A new generation of precision cancer therapies are easier to tolerate than traditional treatment. Who Is at Risk for Liver Cancer After Hepatitis C Treatment? Hepatocellular carcinoma can still occur after hepatitis C is cured, and risk factors differ for people with and without cirrhosis. New Studies Highlight How Immunotherapies Are Transforming Care for Blood Cancers Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects. Hospice Versus Palliative Care: Is There a Difference? Palliative care offers symptom relief for people with serious illness, whether life-threatening or curable, early-stage or advanced. Advertisement Monoclonal Antibody Combo Authorized for COVID-19 PrEP FDA authorizes Evusheld for immunocompromised people who may not respond well to COVID-19 vaccines. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Winter 2022 Check out our latest print edition! Newsfeed Breast Cancer Survival Rates Differ Dramatically by Where People Live New California Law Eases Aid-in-Dying Process High-Tech Screenings May Miss Skin Cancer in People with Darker Skin A Popular Tool for Measuring Distress of Cancer Patients Get Updated Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer Newsfeed Breast Cancer Survival Rates Differ Dramatically by Where People Live New California Law Eases Aid-in-Dying Process High-Tech Screenings May Miss Skin Cancer in People with Darker Skin A Popular Tool for Measuring Distress of Cancer Patients Get Updated Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: